Cargando…
Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues
Clinical use of polygenic risk scores (PRS) will look very different to the more familiar monogenic testing. Here we argue that despite these differences, most of the ethical, legal, and social issues (ELSI) raised in the monogenic setting, such as the relevance of results to family members, the app...
Autores principales: | Lewis, Anna C. F., Green, Robert C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844961/ https://www.ncbi.nlm.nih.gov/pubmed/33509269 http://dx.doi.org/10.1186/s13073-021-00829-7 |
Ejemplares similares
-
Polygenic risk score for embryo selection—not ready for prime time
por: Polyakov, Alex, et al.
Publicado: (2022) -
Polygenic risk scores in the clinic: Translating risk into action
por: Lewis, Anna C.F., et al.
Publicado: (2021) -
Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer’s Disease
por: Vlachakis, Dimitrios, et al.
Publicado: (2021) -
Molecular Tumor Boards: Ethical Issues in the New Era of Data Medicine
por: Stoeklé, Henri-Corto, et al.
Publicado: (2017) -
Potential use of clinical polygenic risk scores in psychiatry – ethical implications and communicating high polygenic risk
por: Palk, A. C., et al.
Publicado: (2019)